Literature DB >> 19056020

The systemic inflammatory response syndrome induces functional changes and relative hyporesponsiveness in neutrophils.

Yoke Lin Fung1, John F Fraser, Peter Wood, Robyn M Minchinton, Christopher C Silliman.   

Abstract

PURPOSE: To study the effects of systemic inflammatory response syndrome (SIRS) on polymorhonuclear neutrophil (PMN) function and phenotype by comparing neutrophils from critically ill patients with SIRS against those from healthy blood donors.
MATERIAL AND METHODS: Intensive care unit patients (n = 110) who met at least one SIRS criterion were recruited to the study. One hundred healthy blood donors were recruited as normal controls.
RESULTS: Polymorphonuclear cells from critically ill patients with SIRS were more resistant to activation than PMNs from healthy donors, but when stimulated had an exaggerated microbicidal response. Buffer-treated PMNs from patients with SIRS had significantly higher CD43 surface expression that may inhibit heterotypic cellular contact or ligand stimulation of membrane receptors, had significantly lower expression of IgG receptor CD16, demonstrated resistance to shedding of L-selectin when primed by platelet-activating factor which could be pro-inflammatory, and had reduced respiratory burst when primed by platelet-activating factor than activated by formyl-Met-Leu-Phe.
CONCLUSION: The phenotypic and functional changes observed in neutrophils in the critically ill indicate that they require a higher level of stimulus to become activated. This may represent an auto-protective mechanism where the neutrophils in the already inflamed host may, by this mechanism, avoid excessive inflammation reducing the risk of further host cell injury and death.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19056020     DOI: 10.1016/j.jcrc.2007.09.004

Source DB:  PubMed          Journal:  J Crit Care        ISSN: 0883-9441            Impact factor:   3.425


  8 in total

1.  Hematologic profile of the fetus with systemic inflammatory response syndrome.

Authors:  Roberto Romero; Zeynep Alpay Savasan; Tinnakorn Chaiworapongsa; Stanley M Berry; Juan Pedro Kusanovic; Sonia S Hassan; Bo Hyun Yoon; Samuel Edwin; Moshe Mazor
Journal:  J Perinat Med       Date:  2011-09-30       Impact factor: 1.901

2.  The augmented neutrophil respiratory burst in response to Escherichia coli is reduced in liver cirrhosis during infection.

Authors:  T Bruns; J Peter; S Hagel; A Herrmann; A Stallmach
Journal:  Clin Exp Immunol       Date:  2011-03-17       Impact factor: 4.330

3.  Respiratory burst function of ovine neutrophils.

Authors:  John-Paul Tung; John F Fraser; Peter Wood; Yoke Lin Fung
Journal:  BMC Immunol       Date:  2009-05-08       Impact factor: 3.615

Review 4.  The role of neutrophils in the pathogenesis of transfusion-related acute lung injury.

Authors:  Yoke Lin Fung; Christopher C Silliman
Journal:  Transfus Med Rev       Date:  2009-10

5.  Age of blood and recipient factors determine the severity of transfusion-related acute lung injury (TRALI).

Authors:  John-Paul Tung; John F Fraser; Maria Nataatmadja; Kathryn I Colebourne; Adrian G Barnett; Kristen M Glenister; Anna Y Zhou; Peter Wood; Christopher C Silliman; Yoke L Fung
Journal:  Crit Care       Date:  2012-02-01       Impact factor: 9.097

6.  Oral neutrophils are an independent marker of the systemic inflammatory response after cardiac bypass.

Authors:  Mary Elizabeth Wilcox; Emmanuel Charbonney; Pablo Perez d'Empaire; Abhijit Duggal; Ruxandra Pinto; Ashkan Javid; Claudia Dos Santos; Gordon David Rubenfeld; Susan Sutherland; Wayne Conrad Liles; Michael Glogauer
Journal:  J Inflamm (Lond)       Date:  2014-10-18       Impact factor: 4.981

7.  Systemic Inflammatory Response Syndrome in Surgical Patients.

Authors:  Jasmina Smajic; Lejla Rakovac Tupkovic; Samir Husic; Selma Sijercic Avdagic; Samir Hodzic; Semir Imamovic
Journal:  Med Arch       Date:  2018-04

Review 8.  Does Neutrophil Phenotype Predict the Survival of Trauma Patients?

Authors:  Esmaeil Mortaz; Seyed Sajjad Zadian; Mehri Shahir; Gert Folkerts; Johan Garssen; Sharon Mumby; Ian M Adcock
Journal:  Front Immunol       Date:  2019-09-06       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.